Atenolol's Inferior Ability to Reduce Central vs Peripheral Blood Pressure Can Be Explained by the Combination of Its Heart Rate-Dependent and Heart Rate-Independent Effects.

Int J Hypertens · 2020 · PMC7201670 · PMID 32395337

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a trend towards significanceP = 0.06so close (0.05 < p ≤ 0.1)

Interdrug differences in SBPA change at the low HR level showed a trend towards significance in our small-volume trial (interdrug ANOVA, P = 0.06).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.